Pfizer to seek full FDA approval for COVID-19 vaccine this month
May 04, 2021 at 09:22 AM EDT
Drugmaker Pfizer said Tuesday it earned $3.5 billion from sales of its COVID-19 vaccine in the first three months of 2021, and plans to ask federal regulators for full approval of the shot by the end of this month.
